Govt Job for Project Associate at Institute of Microbial Technology

Established in 1984, the Institute of Microbial Technology is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research.

Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

In September, 1989, upon completion of the permanent campus, the Institute shifted to occupy an area of about 47 acres, of which the labs covered 22 acres and the residential campus 25 acres.

Post : Project Associate-II =01

Project titled : “Pre-clinical studies and process development for production of tridecaptin M, an antibiotic against colistin resistant Gram negative bacterial infections”

Project Code : MLP-038

Essential Qualification : 1st class in M.Sc. / M.Pharm / M.Tech. in Medicinal Chemistry / Orgainc Chemistry / Pharmaceutical Chemistry with 2 years of experience in synthesis of antibiotics, small molecules, peptides, etc.

Upper Age limit (years) :35

Monthly Emoluments :
(i) Rs. 35,000/- +HRA to Scholars who are selected through a (a) National Eligibility Tests – CSIR-UGC NET including lectureship or GATE or (b) A selection process through National level examinations conducted by Central Government Departments and their agencies and Institutions.
(ii) Rs. 28,000/- +HRA for others who do not fall under (i) above.

ROLLING ADVT. NO. 07-03

Related Posts

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise